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The Mechanism of Apoptosis by the Oleic Acid in HeLa Cells : Caspase-independent Pathway by 
Induction of IκBβ
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Epidemiological studies of breast and pancreatic cancer in several Mediterranean countries, including Southern 
Europe, North Africa, and the Middle East have demonstrated that increased dietary intake of oleic acid may 
reduce a risk of cancer onset. It is well-known that eicosapentaenoic acid  (EPA), which is one of the PUFAs, 
was demonstrated to inhibit proliferation of human leukemic HL-60 cells in vitro. We studied the mechanism of 
apoptosis in HeLa cells by oleic acids as compared with those by EPA, which was previously reported to induces 
apoptosis. In this study, we found that the fragmentation of DNA was detected in agarose electrophoresis and 
apoptotic features, such as cell shrinkage, concentration, and fragmentation of nucleus after addition by 100μM  
of oleic acids and EPA. After 24 hours of medication by EPA and oleic acid, the apoptosis-related proteins (Bax, 
Bcl-2, Fas, cytochrome C, Apaf-1, caspase 3) were analyzed by the Western blot analysis. The Bcl-2 expression was 
inhibited and the ratio of Bax/Bcl-2 expression increased at 50μM and 100μM oleic acid. The apoptosis-related 
proteins (Fas, cytochrome C, Apaf-1, caspase 3) were increased by 50μM  and 100μM  EPA. In contrast, there was 
not the significant change in expression of apoptosis-related proteins (Fas, cytochrome C, Apaf-1, caspase 3) at 50
μM and 100μM oleic acid. Moreover, EPA significantly increased the activity of caspase 3, while oleic acid did not 
affect the caspase 3 activity. Our results indicate that the apoptosis of HeLa cells by oleic acids might be through 
caspase-independent mechanism. We also analyzed the change of NF-κB , IκBα and IκBβ, to which have been, 
recently, paid much attention with relation to apoptosis. We found that NF-κB was dose-dependently inhibited by 
oleic acid and IκBβ was dose-dependently increased, although there was no change in IκBα. Our results suggest 
that the apoptosis by oleic acids might be associated with IκBβ, indicating that the mechanism of apoptosis by oleic 
acid might be different from those by EPA.
Keywords: oleic acids, apoptosis, HeLa cells, NF-kB, IκBα, IκBβ
J Saitama Med School 2002;29:117-123





























































　ヒト子宮頸部癌細胞である H e L a  2 2 9細胞
（大日本製薬，大阪，日本）を用いた．HeLa 229
細胞は37℃，5％ CO2条件下で培養シャーレに
Fetal Bovine Serum（Invitrogen Corp, Carlsbad, USA）
を10 %，ペニシリンストレプトマイシン（Invitrogen 
Corp, Carlsbad, USA）1 %を添加したD-MEM （High 
Glucose） with D-Glucose 4500 mg/dl L-Glu・NaHCO3
（日研生物医学研究所，京都，日本）を用いて，初





















た蛋白を各サンプル20μg  /20μl  になるようにPBSで
調整し，2-メルカプトエタノール存在下で95℃，5分
間熱処理した．泳動，転写後，5％スキムミルクを含
む0.05 % Tween 20/PBSにより非特異的反応をブロッ
クした後，一次抗体としてBcl-2 （mouse monoclonal 
antibody: BD Biosciences PharMingen, SanDiego, 
USA），Bax （rabbit polyclonal antibody: Santa Cruz, 
California, USA），チトクロームC （mouse monoclonal 
antibody: R&B System Inc, Minneapolis, USA），Apaf-1
（goat polyclonal antibody: Santa Cruz, California, 
USA），カスパーゼ 3（rabbit polyclonal antibody: BD 
Biosciences PharMingen, SanDiego, USA），Fas （mouse 
monoclonal antibody: BD Biosciences PharMingen, 
SanDiego, USA），NFκ -B （rabbit polyclonal antibody: 
Santa Cruz, California, USA），IκBα（rabbit polyclonal 
antibody: Santa Cruz, California, USA），IκBβ（rabbit 
polyclonal antibody: Oncogene Research Products, 
Boston,USA）を，2次抗体にはHRP標識抗マウス
Igヤギポリクロナール抗体，抗ウサギIgヤギポリ
クロナール抗体 （ The Binding Site, Birmingham, 







学発光ECLTM（Amersham Pharmacia, Little Chalfont 
Buckinghamshire, England）を利用した．感光用フィ
ルムとしては，ECL系の発光波長に一致した特性を
もつHyperfilm ECL（Amersham Pharmacia, Little 
Chalfont Buckinghamshire, England）を用いた．フィ





およびコマーシャルキット （Promega Corporation, 
Madison, USA）にしたがって，異なった方法にて，
確認した．我々が実施した方法を簡単に記す．細胞
を回収後 400 g，5分間遠心分離し，1 mM EDTA，
5 mM MgCl2，1 mM EGTA，5 mMジチオスレイトール，
1 mM phenyl methionyl sulfonyl fluorideを含む
25 mM Heps-NaOH （pH 7.5） を用いて2回洗浄した．
2分間ソニケーションを行った後，サンプルを4℃，
160,000 gで20分間超遠心分離し，上清の蛋白濃度
をBradford法 で 測 定 し た．50μg 蛋 白 を50μM 
N-acetyl Asp-Glu-Val-Asp-a-4-methyl-coumaryl-7-amide
（ac-DEVD-MCA）を用いて25 mM Heps-NaOH（pH7.5），
10 % sucrose, 5 mM MgCl2，10 mM dithiothreitolから成
るprotease assay buffer 中に37℃，30分間インキュ
ベートした．1 M酢酸を添加して酵素反応させた後，
























て差は認められなかったが （Fig. 3），Fas （CD95），
チトクロームC，Apaf-1，カスパーゼ3の発現が50μM ，
100μM で有意に上昇した （Fig. 4）．一方，オレイン
酸においてBcl-2の発現が抑制され，Bax/Bcl-2の比率
Fig. 1. The fragmentation of DNA was detected in agarose 
electrophoresis 24 hours after additing 100μM  oleic acid (OA) 
and eicosapentaenoic acid (EPA). PMA was used as positive 
control.
Fig. 2. Under a fluorescent microscope, nuclear contraction 
and the typical apoptotic cell (A)which carried out the 
dark stain were detected after 24 hours additing 100μM  
oleic acid (OA) and EPA by Hoechst 33258 stain (original 
magnification, ×400), and the rate of apoptotic cells were 

















IκBβ は濃度依存性に上昇したが，IκB α には変化は認
められなかった （Fig. 6）．
Fig. 3. The change of Bax/Bcl-2 expression in HeLa cells 
with EPA and oleic acid (OA) by Western blotting analysis. 
The Bcl-2 expression was inhibited and the ratio of Bax/Bcl-2 
expression increased at 50μM and 100μM OA.
Fig. 4.The change of Fas (CD95), cytochrome C, Apaf-1 
and caspase 3 expressions in response to EPA in HeLa cells 
by Western blotting analysis. Compared with control, all 
expressions were increased at 50μM and 100μM EPA.
Fig. 6. The change of NF-κB , IκBα and IκBβ expression in 
HeLa cells by oleic acid (OA) by Western blot analysis. NF-κB 
was dose-dependently inhibited by OA and IκBβ was increased 
















Fig. 5. The activity of caspase 3 was significantly increased 
by EPA, but not oleic acid (OA). EPA-induced increase in 































ではNF-κB が濃度依存性に低下し，IκB β が濃度依存
性に増加した．しかしながら，エイコサペンタエン酸
ではNF-κB，IκB α，IκB β の変化を認めなかった．
　近年，正常細胞および癌細胞のアポトーシス調節















てそれはIκB により調節を受けている 38,42)が， IκB に
はIκB α，IκB β，IκB γ，IκB ε，Bcl-3の存在が報告さ
れており 38)，いずれのIκB も，NF-κB の領域部位をマ
スクし，DNAとの結合活性を抑制し，NF-κB の核内
への流入を抑制する作用を有する 43)．さらに，様々な
刺激に際して，IκB  kinaseによりIκB は速やかにリン
酸化され，ユビキチンが負荷され，IκB  がデグラデー
ションをうける 27）．オレイン酸により，IκB β のユビ
キチン化が抑制されていることも考えられる．また，
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